RJA
VCEL icon

Raymond James & Associates’s Vericel Corp VCEL Stock Holding History

Raymond James & Associates’s Portfolio VCEL Stock Details VCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$2.15M Buy
50,908
+3,083
+6% +$147K ﹤0.01% 2180
2024
Q2 		$2.19M Sell
47,825
-608
-1% -$28.7K ﹤0.01% 2110
2024
Q1 		$2.52M Sell
48,433
-88
-0.2% -$3.86K ﹤0.01% 2018
2023
Q4 		$1.73M Sell
48,521
-129
-0.3% -$4.49K ﹤0.01% 2181
2023
Q3 		$1.63M Buy
48,650
+4,513
+10% +$156K ﹤0.01% 2141
2023
Q2 		$1.66M Buy
44,137
+1,376
+3% +$45.2K ﹤0.01% 2177
2023
Q1 		$1.25M Buy
42,761
+2,322
+6% +$67.3K ﹤0.01% 2318
2022
Q4 		$1.07M Sell
40,439
-674
-2% -$16K ﹤0.01% 2394
2022
Q3 		$954K Sell
41,113
-65,057
-61% -$1.78M ﹤0.01% 2426
2022
Q2 		$2.67M Buy
106,170
+1,155
+1% +$34.1K ﹤0.01% 1814
2022
Q1 		$4.01M Buy
105,015
+47,673
+83% +$1.72M ﹤0.01% 1671
2021
Q4 		$2.25M Buy
57,342
+9,314
+19% +$408K ﹤0.01% 2099
2021
Q3 		$2.34M Buy
+48,028
New +$2.49M ﹤0.01% 1995
2021
Q2 		– Sell
-3,631
Closed -$202K – 4217
2021
Q1 		$202K Buy
+3,631
New +$164K ﹤0.01% 3606
2018
Q2 		– Sell
-34,907
Closed -$347K – 3676
2018
Q1 		$347K Buy
+34,907
New +$289K ﹤0.01% 2802
2017
Q3 		– Sell
-10,611
Closed -$35K – 3492
2017
Q2 		$35K Hold
10,611
– – ﹤0.01% 3211
2017
Q1 		$30K Sell
10,611
-995
-9% -$2.81K ﹤0.01% 3183
2016
Q4 		$35K Buy
+11,606
New +$29.8K ﹤0.01% 3115

Other funds holding VCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raymond James & Associates's VCEL Position: Q3 2024 in Review

Raymond James & Associates increased its Vericel Corp (VCEL) stake by 6.4% in Q3 2024, buying an estimated $147K and bringing the position to 50,908 shares worth $2.15M. The position accounts for ﹤0.01% of the portfolio, ranked #2180.

Raymond James & Associates first reported a position in VCEL in Q4 2016 and has held it in 18 quarters since. The position peaked at $4.01M in Q1 2022. 268 funds tracked by Wall St. Rank hold VCEL as of Q3 2024.

  • Raymond James & Associates held 50,908 shares of Vericel Corp worth $2.15M as of Q3 2024.
  • Raymond James & Associates bought 3,083 Vericel Corp shares in Q3 2024, an estimated $147K.
  • Vericel Corp made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2180 holding.
  • Raymond James & Associates first reported a position in Vericel Corp in Q4 2016 and has held it in 18 quarters since.
  • Raymond James & Associates's Vericel Corp position peaked at $4.01M in Q1 2022.
  • 268 funds tracked by Wall St. Rank held Vericel Corp as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.